Noom, a Chelsea-based company whose app helps users lose weight, is the first program to achieve full recognition for diabetes prevention from the federal Centers for Disease Control and Prevention.
The recognition follows a study published last year in BMJ Open Diabetes Research and Carethat showed 64% of people who completed Noom’s diabetes-prevention program lost at least 5% of their body weight.
“It’s great to have the CDC put its seal of approval on our program,” said Artem Petakov, the company’s president and co-founder. “Digital care for pre-chronic conditions is new, and people are naturally skeptical. There’s now a great scientific recognition.”